Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Grémy

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Health Physics|August 12, 2010
Isotopic and elemental composition of plutonium/americium oxides influence pulmonary and extra-pulmonary distribution after inhalation in ratsA Van der Meeren, O Grémy
Radiation Protection Dosimetry|December 7, 2010
MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapyP Fritsch, O Grémy, C Hurtgen, et al.
Radiation Research|August 1, 2008
In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPAA L Sérandour, O Grémy, M Fréchou, et al.
Health Physics|September 15, 2010
Structure of a single model to describe plutonium and americium decorporation by DTPA treatmentsP Fritsch, A L Sérandour, O Grémy, et al.
Radiation Research|July 8, 2009
Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatmentsP Fritsch, A L Sérandour, O Grémy, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Health Physics|August 12, 2010
Isotopic and elemental composition of plutonium/americium oxides influence pulmonary and extra-pulmonary distribution after inhalation in ratsA Van der Meeren, O Grémy
Radiation Protection Dosimetry|December 7, 2010
MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapyP Fritsch, O Grémy, C Hurtgen, et al.
Radiation Research|August 1, 2008
In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPAA L Sérandour, O Grémy, M Fréchou, et al.
Health Physics|September 15, 2010
Structure of a single model to describe plutonium and americium decorporation by DTPA treatmentsP Fritsch, A L Sérandour, O Grémy, et al.
Radiation Research|July 8, 2009
Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatmentsP Fritsch, A L Sérandour, O Grémy, et al.
Pageof 1